A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The first of its kind to be approved by the FDA, the twice-yearly shot lenacapavir reportedly nearly eliminated new ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

executive director of the HIV advocacy nonprofit group AVAC. Yeztugo (generic name lenacapavir), which is given by health care workers in clinics, is significantly more effective than the existing ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...